Krishna Institute of Medical Sciences Limited (NSE:KIMS)
India
· Delayed Price · Currency is INR 664.05
-12.70 (-1.88%)
Jun 27, 2025, 3:30 PM IST
NSE:KIMS Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 30,351 | 24,981 | 21,977 | 16,508 | 13,299 | Upgrade
|
| Revenue | 30,351 | 24,981 | 21,977 | 16,508 | 13,299 | Upgrade
|
| Revenue Growth (YoY) | 21.49% | 13.67% | 33.13% | 24.13% | 18.46% | Upgrade
|
| Cost of Revenue | 11,264 | 10,158 | 8,793 | 6,676 | 5,535 | Upgrade
|
| Gross Profit | 19,087 | 14,823 | 13,184 | 9,832 | 7,764 | Upgrade
|
| Selling, General & Admin | - | 494.75 | 352.46 | 205.01 | 178.24 | Upgrade
|
| Other Operating Expenses | 11,258 | 7,920 | 6,784 | 4,429 | 3,851 | Upgrade
|
| Operating Expenses | 13,030 | 9,880 | 8,429 | 5,361 | 4,733 | Upgrade
|
| Operating Income | 6,057 | 4,944 | 4,755 | 4,471 | 3,031 | Upgrade
|
| Interest Expense | -903 | -464.34 | -293.18 | -159.21 | -293.02 | Upgrade
|
| Interest & Investment Income | - | 22.91 | 95.32 | 122.82 | 57.99 | Upgrade
|
| Earnings From Equity Investments | - | -2.71 | - | 95.1 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 319 | 39.99 | 29.43 | 23.15 | -2.9 | Upgrade
|
| EBT Excluding Unusual Items | 5,473 | 4,539 | 4,586 | 4,553 | 2,793 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 40.86 | 30.01 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 3.76 | 6.1 | -27.17 | -10.79 | Upgrade
|
| Other Unusual Items | 108 | 12.39 | 226.72 | 42.41 | 7.52 | Upgrade
|
| Pretax Income | 5,581 | 4,596 | 4,849 | 4,569 | 2,790 | Upgrade
|
| Income Tax Expense | 1,433 | 1,236 | 1,191 | 1,131 | 735.36 | Upgrade
|
| Earnings From Continuing Operations | 4,148 | 3,360 | 3,658 | 3,438 | 2,055 | Upgrade
|
| Minority Interest in Earnings | -303 | -258.6 | -294.91 | -111.1 | -42.6 | Upgrade
|
| Net Income | 3,845 | 3,101 | 3,363 | 3,327 | 2,012 | Upgrade
|
| Net Income to Common | 3,845 | 3,101 | 3,363 | 3,327 | 2,012 | Upgrade
|
| Net Income Growth | 23.97% | -7.78% | 1.09% | 65.33% | 68.83% | Upgrade
|
| Shares Outstanding (Basic) | 400 | 400 | 400 | 397 | 374 | Upgrade
|
| Shares Outstanding (Diluted) | 400 | 400 | 400 | 397 | 381 | Upgrade
|
| Shares Change (YoY) | -0.01% | - | 0.74% | 4.32% | 1.42% | Upgrade
|
| EPS (Basic) | 9.61 | 7.75 | 8.41 | 8.38 | 5.37 | Upgrade
|
| EPS (Diluted) | 9.61 | 7.75 | 8.41 | 8.38 | 5.28 | Upgrade
|
| EPS Growth | 24.00% | -7.79% | 0.35% | 58.51% | 66.48% | Upgrade
|
| Free Cash Flow | -4,271 | -1,263 | -1,424 | 1,537 | 2,615 | Upgrade
|
| Free Cash Flow Per Share | -10.68 | -3.15 | -3.56 | 3.87 | 6.87 | Upgrade
|
| Gross Margin | 62.89% | 59.34% | 59.99% | 59.56% | 58.38% | Upgrade
|
| Operating Margin | 19.96% | 19.79% | 21.63% | 27.09% | 22.79% | Upgrade
|
| Profit Margin | 12.67% | 12.41% | 15.30% | 20.15% | 15.13% | Upgrade
|
| Free Cash Flow Margin | -14.07% | -5.05% | -6.48% | 9.31% | 19.67% | Upgrade
|
| EBITDA | 7,829 | 6,231 | 5,828 | 5,120 | 3,661 | Upgrade
|
| EBITDA Margin | 25.80% | 24.94% | 26.52% | 31.01% | 27.52% | Upgrade
|
| D&A For EBITDA | 1,772 | 1,288 | 1,073 | 648.09 | 629.24 | Upgrade
|
| EBIT | 6,057 | 4,944 | 4,755 | 4,471 | 3,031 | Upgrade
|
| EBIT Margin | 19.96% | 19.79% | 21.63% | 27.09% | 22.79% | Upgrade
|
| Effective Tax Rate | 25.68% | 26.90% | 24.56% | 24.75% | 26.36% | Upgrade
|
| Revenue as Reported | 30,670 | 25,112 | 22,236 | 16,711 | 13,401 | Upgrade
|
| Advertising Expenses | - | 251.59 | 197.39 | 111.51 | 91.81 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.